Michael Wysolmerski

KO client LeadGenius, a leading provider of B2B lead generation and data enrichment services, recently announced the acquisition of the software assets of WhoKnows, a technology company known for its predictive analytics and AI-driven data insights expertise. The acquisition creates a comprehensive solution that will offer unprecedented sales intelligence to…

KO client Backbone PLM, a product development platform that enables brands to make products smarter, faster, and at scale, was recently acquired by Bamboo Rose, the leading collaborative product development, sourcing, and supply chain platform for retailers and consumer brands. According to the press release, this combination catapults creativity and…

KO client Ampush, a leading growth marketing agency, was recently acquired by Tinuiti, the largest independent performance marketing firm across Streaming TV, Google, Meta, and Amazon. The acquisition enhances Tinuiti’s industry award-winning paid social capabilities. Ampush CEO Jon Oberlander will now lead the Tinuiti Social Division as EVP, Social. In…

KO Client Adaptive Energy, a globally recognized designer and manufacturer of solid oxide fuel cells (SOFC), has been acquired by unmanned and autonomous technology leader Edge Autonomy. The KO team, led by partner Jon Taylor, attorney Matt Burns, and attorney Michael Wysolmerski, represented Adaptive Energy in the deal. Adaptive Energy…

KO Client Plato BioPharma, Inc., a Colorado-based pharmacology research and drug discovery company, has been acquired by leading contract research organization Inotiv, Inc. The KO team, led by partner John Gaddis, represented Plato BioPharma in the acquisition. Plato BioPharma specializes in cardiovascular, renal, pulmonary and hepatic therapeutic areas, specifically within…

Sydnexis, Inc., a clinical stage biopharmaceutical company, has completed a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund. The KO team, led by partners Kevin Gibson and Brad Schoenfeld, represented Sydnexis. The company sees progressive myopia (nearsightedness) in children as a “significant…